Nephrologie pp 32-39 | Cite as

Vergleichende Studie des Einsatzes von Erythropoietin (i.v. vs. s.c.) zur Korrektur der renalen Anämie

  • G. Stein
  • H. Sperschneider
  • H. Thieler
  • W. Dutz
  • S. Hans
  • D. Voigt
  • M. Marx
  • J. Engelmann
  • P. Scigalla
Conference paper
Part of the Innovative Aspekte der klinischen Medizin book series (KLIN MED, volume 2)

Zusammenfassung

Die Wirksamkeit von rhEPO hinsichtlich der Korrektur einer renalen Anämie ist durch klinische Studien belegt [1, 5, 6, 11, 13].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bommer J, Alexiou C, Müller-Bühl E, Eifert J, Ritz E (1987) Recombinant human erythropoietin therapy in haemodialysis patients — dose determination and clinical experience. Nephrol Dial Transplant 2:238–242PubMedGoogle Scholar
  2. 2.
    Bommer J, Ritz E, Weinreich T, Bommer G, Ziegler T (1988) Subcutaneous erythropoietin. Lancet II:406CrossRefGoogle Scholar
  3. 3.
    Bommer J, Samtleben W, Koch KM, Baldamus CA, Grützmacher P, Scigalla P (1989) Variations of recombinant human erythropoietin application in hemodialysis patients. Contrib Nephrol 76:149–156PubMedGoogle Scholar
  4. 4.
    Casati S, Passerini P, Campise MR, Graziani G, Cesana B, Perisic N, Ponticelli C (1987) Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having hemodialysis. Dr Med J 295:1017–1021CrossRefGoogle Scholar
  5. 5.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73–78PubMedCrossRefGoogle Scholar
  6. 6.
    Eschbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW (1989) USA Multicenter Clinical Trial with Recombinant Human Erythropoietin (Amgen). Contrib Nephrol 76:160–165PubMedGoogle Scholar
  7. 7.
    Granolleras C, Branger B, Bean MC, Deschodt G, Alsabadani B, Shaldon S (1989) Experience with daily self-administered subcutaneous erythropoietin Contrib Nephrol 76:143–148Google Scholar
  8. 8.
    Grützmacher P, Bergmann M, Weinreich T, Nattermann U, Reimers E, Pollok N (1988) Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis. Contrib Nephrol 66:104–113PubMedGoogle Scholar
  9. 9.
    Kampf D, Kahl A, Passlick J, Pustelnik A, Eckardt K-U, Ehmer B, Jacobs C, Baumelou A, Grabensee B, Gahl GM (1989) Single-dose kinetics of recombinant human erythropoietin after intravenous, subcutaneous and intraperitoneal administration. Preliminary results. Contrib Nephrol 76:106–111PubMedGoogle Scholar
  10. 10.
    Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfäffl W, Baldamus CA, Scigalla P (1988) Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Contrib Nephrol 66:94–103PubMedGoogle Scholar
  11. 11.
    Pollok M, Bommer J, Gurland HJ, Koch KM, Schoeppe W, Scigalla P, Baldamus CA (1989) Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. Contrib Nephrol 76:201–211PubMedGoogle Scholar
  12. 12.
    Samtleben W, Baldamus CA, Bommer J, Fassbinder W, Nonnast-Daniel B, Gurland HJ (1988) Blood pressure changes during treatment with recombinant human erythropoietin. Contrib Nephrol 66:114–122PubMedGoogle Scholar
  13. 13.
    Winearis CG, Oliver D, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin derived recombinant DNA on the anemia of patients maintained by chronic hemodialysis. Lancet II:1175–1178CrossRefGoogle Scholar
  14. 14.
    Zehnter E, Pollok M, Ziegenhagen D, Bramsiepe P, Longere F, Baldamus CA, Wellner U, Waters W (1988) Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin. Contrib Nephrol 66:149–155PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • G. Stein
  • H. Sperschneider
  • H. Thieler
  • W. Dutz
  • S. Hans
  • D. Voigt
  • M. Marx
  • J. Engelmann
  • P. Scigalla

There are no affiliations available

Personalised recommendations